Associated Genetic Biomarkers
NCI Definition: A solitary adenocarcinoma arising from the lung measuring 3 cm or less. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous. 
Bronchioloalveolar carcinomas most frequently harbor alterations in EGFR .
EGFR Mutation are the most common alterations in bronchioloalveolar carcinoma .
There are 2 clinical trials for bronchioloalveolar carcinoma, of which 2 are open and 0 are completed or closed. Of the trials that contain bronchioloalveolar carcinoma as an inclusion criterion, 2 are phase 2 (2 open).
Docetaxel, nintedanib, and nivolumab are the most common interventions in bronchioloalveolar carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.